Jeffrey Sturchio, Senior Partner

Rabin Martin Rabin Martin works with multi-national corporations, non-profit and advocacy organizations, foundations, major universities, think tanks and government to help clients improve health and shape policy.
110 W. 57th Street, 4th Floor New York NY 10019 (212) 365-7460 Fax: (212) 365-7461

Management Consulting

Advocacy and Public Policy

Communications

Philanthropic Initiatives

Jeffrey Sturchio, Senior Partner

Jeffrey L. Sturchio is Senior Partner at Rabin Martin. Before joining Rabin Martin, Dr. Sturchio was President and CEO of the Global Health Council, the world's largest membership alliance of public health organizations and professionals (in more than 140 countries on six continents) dedicated to saving lives by improving health throughout the world.

Dr. Sturchio joined the GHC in August 2009, following nearly twenty years at Merck & Co., Inc., where he was Vice President, Corporate Responsibility, and managed a portfolio of activities including Merck's corporate philanthropy, the Merck Institute for Science Education, the Merck Childhood Asthma Network, global health partnerships (including the Merck MECTIZAN Donation Program), global HIV/AIDS access programs, corporate responsibility reporting and the Merck Archives. He also served as President of The Merck Company Foundation, a US-based, private charitable foundation established in 1957 by Merck & Co., Inc., which is Merck's chief source of funding support to qualified non-profit, charitable organizations.   (In 2007, Merck made cash contributions of $62 million, donations of medicines and vaccines -- including the Merck Medical Outreach Program and the MECTIZAN Donation Program -- of $605 million, and donations of medicines through the Merck Patient Assistance Program of $161 million.)   Since 2000, Dr. Sturchio was centrally involved in Merck's participation in the UN/Industry Accelerating Access Initiative to help improve HIV/AIDS care and treatment in the developing world. He was a member of the board of the African Comprehensive HIV/AIDS Partnerships in Botswana (2005-2009) and a member of the private sector delegation to the Board of the Global Fund to Fight AIDS, TB and Malaria (2002-2008).   He joined Merck in June 1989 as the Company's first Corporate Archivist.

In 2008-2009, he was also Chairman of the Corporate Council on Africa, whose 150 member companies represent some 85 per cent of total U.S. private sector investment in Africa and work closely with governments, multilateral organizations, NGOs and business to improve the trade and investment climate on the African continent and to raise the profile of Africa in the US business community.   Dr. Sturchio is also a Visiting Scholar at the Institute for Applied Economics, Global Health and the Study of Business Enterprise at The Johns Hopkins University and a member of the Global Agenda Council on Health of the World Economic Forum.

Dr. Sturchio received an A.B. in history (1973) from Princeton University and a Ph.D. in the history & sociology of science from the University of Pennsylvania (1981). His previous positions include the AT&T Archives, the Beckman Center for the History of Chemistry at the University of Pennsylvania, Rutgers University, and the New Jersey Institute of Technology. He has also been a Postdoctoral Fellow and Senior Fellow at the Smithsonian Institution's National Museum of American History (NMAH) and a Visiting Fellow of LSE Health and Social Care at the London School of Economics.   In 2004 he was elected a Fellow of the American Association for the Advancement of Science. In 2010 he was elected a Member of the Council on Foreign Relations.

His publications include Chemistry in America, 1876-1976: Historical Indicators (Reidel, 1985; paperback edition, 1988), written with A. Thackray, P. T. Carroll, and R. F. Bud; Values & Visions: A Merck Century (Merck & Co., Inc., 1991); "Pharmaceutical firms and the transition to biotechnology: a study in strategic innovation" (with L. Galambos), Business History Review 72 (Summer 1998): 250-278; "Successful public-private partnerships in global health: lessons from the MECTIZAN Donation Program," (with B. Colatrella), in The Economics of Essential Medicines, ed. by B. Granville (London: Royal Institute of International Affairs, 2002); "Partnership for action: the experience of the Accelerating Access Initiative, 2000-04, and lessons learned," in Delivering Essential Medicines, ed. by A. Attaran and B. Granville (London: Royal Institute of International Affairs, 2004); "Business and global health in an era of globalization: reflections on public/private partnerships as a cultural innovation," in Cultural Politics in a Global Age: Uncertainty , Solidarity and Innovation, ed. by D. Held and H. Moore (Oxford, UK: Oneworld Publications, 2008); and "Business engagement in public programs: the pharmaceutical industry's contribution to public health and the Millennium Development Goals." Corporate Governance: The International Journal of Business in Society 8, no. 4 (2008): 482 - 489.

Previous Next

RABIN MARTIN NAMES BILL MARTIN CHIEF EXECUTIVE OFFICER: Leading Consulting Firm Celebrates 10 Years of Making a Difference in Health

NEW YORK, March 27, 2012 - Rabin Martin, a leading public health consulting firm, announced today that Bill Martin will take the helm as President and Chief Executive Officer of the firm. Read more...

MERCK JOINS GLOBAL FIGHT TO HELP SAVE WOMEN'S LIVES DURING PREGNANCY AND CHILDBIRTH: President and CEO Ken Frazier Announces 10-Year, $500 Million Mobilization

NEW YORK, Sep 20, 2011 (BUSINESS WIRE) -- --"Merck for Mothers" Joins Global Community to Apply Scientific and Business Expertise in Support of UN Goal to Decrease the Maternal Mortality Ratio by 75 Percent. Read more...

JOHNSON & JOHNSON MAKES STRONG PROGRESS IN FIRST YEAR OF INITIATIVE TO IMPROVE HEALTH OF MILLIONS OF WOMEN AND CHILDREN IN THE DEVELOPING WORLD

Innovative Partnerships with UN Agencies and NGOs to Help Ensure Measurable Health Impact in Five-Year Commitment to UN's Global Strategy. Additional New Efforts Aim to Prevent Chronic Disease and Improve Health Worker Training Read More

GLOBAL HEALTH COUNCIL CEO JEFFREY L. STURCHIO TO BECOME SENIOR PARTNER AT RABIN MARTIN: Key Staff Additions Diversify Senior Team

New York, July 19, 2011- Rabin Martin, a leading global management consultancy working at the crossroads of health, announced today that Dr. Jeffrey L. Sturchio, president & Chief Executive Officer of the Global Health Council, will join the firm in September as Senior Partner. Read more...

BLACK TREATMENT ADOVOCACY NETWORK (BTAN) VOLUNTEER FEATURED IN USA TODAY ARTICLE ON AIDS IN THE SOUTH

RABIN STRATEGIC PARTNERS BECOMES RABIN MARTIN

Management Consulting Initiatives for the United Nations; Major U.S. Corporations; Non-Profits and Foundation in Nigeria, India and the US; and Driving Change Read more...

COLUMBIA UNIVERSITY'S TEENSCREEN LAUNCHES REGISTRY OF PRIMARY CARE PROVIDERS WHO OFFER MENTAL HEALTH SCREENING FOR ADOLESCENTS

TIBOTEC SIGNS MULTIPLE AGREEMENTS WITH GENERIC MANUFACTURERS TO PROVIDE ACCESS TO NEW HIV TREATMENT

SISTERLOVE, INC. AND MERCK LAUNCH "EVERYONE HAS A STORY" SERIES: UNIQUE HIV/AIDS TREATMENT AND CARE EDUCATIONAL SERIES, PARTNERSHIP HELPS HIV + WOMEN OF COLOR SHARE THEIR STORIES

BLACK AIDS INSTITUTE, IN PARTNERSHIP WITH MERCK, LAUNCHES DYNAMIC NATIONAL HIV/AIDS TREATMENT AND CARE ADVOCACY NETWORK

2010 EMERGES AS HISTORIC YEAR OF DECISIVE ACTION TO SAVE THE LIVES OF MORE THAN 10 MILLION WOMEN AND CHILDREN BY 2015

TIBOTEC THERAPEUTICS DEBUTS INNOVATIVE WEB PORTAL FOR HIV/AIDS FRONT-LINE SERVICE PROVIDERS FREE, CENTRALIZED RESOURCE DESIGNED TO HELP OVERCOME SOME BARRIERS TO SUPPORTIVE CARE

TEENSCREEN CENTER AT COLUMBIA UNIVERSITY OFFERS FREE RESOURCES TO HELP COMPLY WITH NEW FEDERAL RECOMMENDATIONS

WELLCOME TRUST AND MERCK ANNOUNCE JOINT VENTURE

MERCK AND JOHNSON & JOHNSON RECIEVE TOP GRADES FROM ACTIVIST